Enbrel and Parathyroid tumor benign - a phase IV clinical study of FDA data

Summary:

Parathyroid tumor benign is reported as a side effect among people who take Enbrel (etanercept), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Methotrexate, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Parathyroid tumor benign when taking Enbrel. It is created by eHealthMe based on reports of 662,905 people who have side effects when taking Enbrel from the FDA, and is updated regularly.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.

What is Parathyroid tumor benign?

Parathyroid tumor benign is found to be associated with 164 drugs and 230 conditions by eHealthMe. Check the latest studies of Parathyroid tumor benign.

On Jul, 12, 2026

662,905 people reported to have side effects when taking Enbrel.
Among them, 21 people (0.0%) have Parathyroid tumor benign.

Could Enbrel cause Parathyroid tumor benign?

Among these 21 people:

How long have people been on Enbrel when they have Parathyroid tumor benign? *

What is the gender of people who have Parathyroid tumor benign when taking Enbrel? *

female: 100 %
male: 0.0 %

What is the age of people who have Parathyroid tumor benign when taking Enbrel? *

What are other drugs people take besides Enbrel? *

What are other side effects people have besides Parathyroid tumor benign? *

Joint Pain: 8 people, 38.10%
Diabetes: 6 people, 28.57%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 6 people, 28.57%
Fall: 5 people, 23.81%
Joint Instability (a condition in which the joints aren't sufficiently supported): 4 people, 19.05%
Mobility Decreased (ability to move is reduced): 4 people, 19.05%
Injection Site Reaction: 4 people, 19.05%
Fatigue (feeling of tiredness): 4 people, 19.05%
Pain: 4 people, 19.05%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 3 people, 14.29%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 19.05%
Seasonal Allergy (allergic condition due to certain season): 2 people, 9.52%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 9.52%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Parathyroid tumor benign?

- Check whether Parathyroid tumor benign is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enbrel:

Enbrel (664,678 reports)

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Parathyroid tumor benign:

Parathyroid tumor benign (164 drugs)

Browse all the conditions that are associated with Parathyroid tumor benign:

Parathyroid tumor benign (230 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.